Psychedelics, Hormones, and Chronic Pain in Women

Court Wing, Jagpaul Kaur Deol, Sinziana Pop, Jasmine Virdi

Tuesday 31 March, 2026 8PM CET (7PM GMT, 3PM EDT, 12PM PDT)

Online via Zoom

Add to Calendar

This event is a collaboration between OPEN Foundation and the Psychedelics & Pain Association. You can attend for free once you create an account for the General tier of the OPEN Community here. There are no costs involved in this.

Chronic pain disproportionately affects women, with many pain conditions, including chronic pelvic pain, fibromyalgia, and reproductive health-related disorders, more prevalent and often more severe in women than in men. At the same time, women’s pain is frequently dismissed, under-researched, and historically underrepresented in clinical trials. On average, it takes far longer for their primary pain condition to be correctly diagnosed and treated, often after years of having it dismissed as psychosomatic. Hormonal dynamics, particularly the role of estrogen and its interaction with inflammatory and serotonergic systems, are increasingly recognised as central to understanding both pain perception and treatment response.

This panel will explore how emerging psychedelic research may begin to address unmet needs in women’s chronic pain care. As psychedelics re-enter clinical contexts, questions are arising about their interaction with hormonal cycles, their influence on serotonin pathways, and their potential role in modulating inflammatory and affective dimensions of chronic pain. While much of the research is still developing, a growing body of evidence suggests psychedelics may offer new avenues for conditions that have long lacked effective treatment options.

Whether you are navigating chronic pain firsthand, supporting someone you love, or simply wishing to better understand the realities many women face, this conversation offers an opportunity to learn more about the biological, medical, and social dimensions shaping women’s experiences of pain.

In honour of Women’s History Month, this collaborative event invites clinicians and researchers to reflect on the intersections of gender, biology, and psychedelic science. Together, we will examine the implications of hormonal dynamics for psychedelic efficacy, consider gaps in current research, and discuss how future trials and clinical practice might more meaningfully account for women’s lived experiences of pain.

READY TO ATTEND?

ATTEND FOR FREE AS A MEMBER

This is one of the free events we organise for the General tier of the OPEN Community. Start your membership for free today, and sign up for the event inside the community platform.

ABOUT THE SPEAKERs

Court Wing | Co-founder & President of Psychedelics & Pain Association and Founder & CEO of REMAP Therapeutics

A former chronic pain sufferer, Court Wing is the founder and CEO of REMAP Therapeutics and a co-founder of the Psychedelics & Pain Association. REMAP Therapeutics is devoted to the development of formal psychedelic rehabilitation sessions and cohesive best practices for many treatment-resistant chronic pain conditions. Court is an accomplished performance and pain professional with over 14 years of formal Ki-Aikido study and 30 years of experience in maximizing the athletic performance of his clients, helping countless individuals overcome injury to return to competition and daily life. He is a certified Z-Health Master Trainer and was co-founder of NYC’s first CrossFit.

In 2020, Court was a study participant in NYU’s clinical trial of Psilocybin for Major Depressive Disorder. By the end of his “dosing” day in the trial, he was in full remission, no longer qualifying for the diagnosis of depression. More astounding were the lateral benefits; he was also no longer suffering from low-to-moderate chronic pain and related neurological issues from previous injuries. Court’s commitment to further investigate the healing potential of psychedelics stems from his direct experience as a participant in this psilocybin trial. With his extensive experience in applied neurophysiology for pain & performance, he immediately realized psychedelics were going to completely change the way we are able to treat chronic pain.

Jagpaul Kaur Deol | PharmD/PhD©, RPh, Founder of Atma Apothecare

Jagpaul Kaur Deol is a psychedelic therapy researcher, clinical pharmacist, doctoral candidate, MAPS Canada Board of Directors and Clinical Advisor/Trainer for TheraPsil. She specializes in psychiatry, chronic pain, and women’s health across the lifespan. With over 15 years of clinical experience, Jag works at the intersection of neuroscience, pharmacology, and patient-centred care models for psychedelic medicines. Jag has supported more than 100 clinical applications for legal psychedelic access in Canada and advises private practice or hospital-based care teams on the responsible integration of psychedelic-assisted therapies into real-world care.

Her work bridges pharmaceutical care with emerging psychedelic-assisted approaches. Jag’s practice focuses on treatment-resistant conditions with particular attention to sex differences in neurobiology and the unique health needs of women. In her former role as an Assistant Professor at UBC, she co-led the Reproductive/Sexual Health module and began researching hormonal transitions and impacts on treatment outcomes. She is passionate about advancing evidence-informed, compassionate models of care that expand therapeutic options for patients who have not benefited from conventional treatments.

Sinziana Pop | PhD, Research Associate with Hystelica

Sinziana Pop is a neuroscientist with over a decade of experience researching brain function and evolution. In recent years, her focus has shifted from curiosity-driven “blue sky” neuroscience to exploring unconventional approaches to treating chronic pain in women. Motivated by her lived experience of chronic pain, her work centres on advancing women’s healthcare and promoting mind–body integration as a core component of effective treatment.

Together with Dr. Grace Blest-Hopley (Hystelica), she is currently designing novel therapeutic approaches that combine psychedelic-assisted and somatic therapies tailored to women’s unique biology, life experiences, and needs.

Jasmine Virdi | Professional Events Coordinator at the OPEN Foundation

Jasmine Virdi (she/her) is a writer, educator, lyric essayist, activist, integrative somatic coach, and lover of this earthly existence. Her creative and written work explores plant medicines, spirituality, deep ecology, Indigenous and more-than-human rights, reworlding, and liberatory praxis. Her writing has appeared in DoubleBlind Magazine, Open Democracy, and the Chacruna Institute. She is also a contributing author of the book chapter “Psychedelics and Death: Transitioning from this World with Consciousness” in Women and Psychedelics: Uncovering Invisible Voices (Synergetic Press, 2024).

Holding an MSc in Transpersonal Psychology, Jasmine offers private coaching and mentorship. As an advocate for decolonising healing practices, she integrates earth-based wisdom with somatic, trauma-informed approaches that honour both body and spirit. Her monthly newsletter, Foraged Wisdom, gathers insights on world-building amidst systems collapse, weaving together animism, earth-based wisdom, grief work, decolonisation, magic, and the richness of the human spirit.